```html

Quercetin Overuse Syndrome – A Comprehensive Medical Guide

Overview

Quercetin overuse syndrome (QOS) refers to a collection of adverse health effects that appear when a person ingests excessive amounts of the flavonoid quercetin, most often through high‑dose dietary supplements. While quercetin is naturally present in foods such as apples, onions, berries, and tea, the doses used in supplemental form can be 10‑100 times higher than what is obtained from a typical diet.

QOS is not a formally recognized disease in major classification systems (ICD‑10, ICD‑11), but clinicians have reported consistent patterns of toxicity that warrant attention. The majority of reported cases involve adults aged 18–65 who use quercetin for its purported anti‑inflammatory, antihistamine, or performance‑enhancing effects.

Because quercetin supplements are sold over‑the‑counter and marketed as “natural,” the true prevalence of QOS is uncertain. A 2022 review of case reports and pharmacovigilance databases identified approximately 200 documented cases worldwide over the past decade, with the United States accounting for roughly 45 % of reports (CDC, 2022). Under‑reporting is likely, as mild symptoms often resolve without medical attention.

Symptoms

Symptoms usually develop within days to weeks of initiating high‑dose quercetin (≥1 g/day). The clinical picture is broad because quercetin affects multiple organ systems.

Gastrointestinal

• Nausea and vomiting – a burning sensation in the stomach.
• Diarrhea – loose, watery stools, sometimes with cramping.
• Abdominal pain – sharp or dull pain, often in the epigastric region.

Renal & Electrolyte Disturbances

• Kidney stones – quercetin metabolites can crystallize, especially in susceptible individuals.
• Electrolyte imbalances – low potassium (hypokalemia) and low magnesium due to increased urinary excretion.

Neurological

• Headache – throbbing, often worse in the morning.
• Dizziness or vertigo – sensation of spinning or light‑headedness.
• Peripheral neuropathy – tingling or burning in the hands/feet after prolonged high‑dose use.

Cardiovascular

• Palpitations – irregular or rapid heartbeats.
• Hypotension – low blood pressure, especially when standing.

Hepatic

• Elevated liver enzymes (ALT, AST) – often discovered on routine labs.
• Jaundice – yellowing of the skin or eyes in severe cases.

Allergic‑like Reactions

• Rash or urticaria – red, itchy welts.
• Respiratory distress – rare, but can occur in hypersensitive individuals.

Other

• Fatigue – generalized lack of energy.
• Weight loss – due to chronic GI upset.

Causes and Risk Factors

Quercetin overuse syndrome results from ingesting a dose that overwhelms the body’s ability to metabolize and excrete the compound.

• High‑dose supplementation – most commercial capsules contain 500 mg–1 g per tablet; taking several tablets daily is the primary cause.
• Concurrent use of interacting substances – medications that inhibit CYP3A4 (e.g., ketoconazole, grapefruit juice) or that are also metabolized by the same pathways can raise quercetin levels.
• Pre‑existing kidney or liver disease – reduces clearance and amplifies toxicity.
• Genetic polymorphisms – variations in the UGT1A1 or SULT1A1 enzymes affect quercetin conjugation.
• Dehydration or high‑protein diets – increase the risk of crystal formation in the urinary tract.

Diagnosis

There is no single test for QOS; diagnosis is clinical, supported by laboratory and imaging findings.

Step‑by‑step approach

1. History taking – document supplement type, dose, duration, and any co‑medications.
2. Physical examination – focus on abdominal tenderness, skin changes, and signs of dehydration.
3. Laboratory tests
   • Complete metabolic panel (CMP) – looks for elevated liver enzymes, electrolytes, and renal function.
   • Urinalysis – assesses for hematuria, crystals, and proteinuria.
   • Serum quercetin level (research labs only) – useful in research settings, not routine.
4. Imaging
   • Abdominal ultrasound or non‑contrast CT – can detect kidney stones or gallbladder sludge secondary to quercetin metabolites.
5. Exclusion of other causes – rule out infectious gastroenteritis, gallstones, drug‑induced liver injury, etc.

Treatment Options

The cornerstone of therapy is cessation of the offending supplement and supportive care.

Immediate Measures

• Stop quercetin intake – even a single dose can be harmful when toxicity is present.
• Hydration – oral or IV fluids (2–3 L/day) to promote renal flushing and prevent stone formation.

Pharmacological Management

• Anti‑emetics (e.g., ondansetron) for nausea/vomiting.
• Electrolyte replacement – oral or IV potassium and magnesium as needed.
• Liver protectants – N‑acetylcysteine (NAC) has been used off‑label for flavonoid‑induced hepatotoxicity (case series, *J Clin Gastroenterol*, 2021).
• Pain control – acetaminophen or low‑dose NSAIDs if renal function allows.

Procedural Interventions

• Kidney stone management – ureteroscopy or extracorporeal shock wave lithotripsy (ESWL) if stones are >5 mm.
• Dialysis – rare, reserved for severe renal failure.

Long‑Term Lifestyle Adjustments

• Adopt a balanced diet rich in natural sources of quercetin (≤30 mg/day) rather than supplements.
• Maintain adequate hydration (≥2 L water/day) to aid renal clearance.
• Regular monitoring of liver and kidney labs for 3–6 months after toxicity resolution.

Living with Quercetin Overuse Syndrome

Even after acute symptoms subside, patients may need ongoing strategies to prevent recurrence.

• Keep a supplement diary – record brand, dose, and timing.
• Read labels carefully – many “multivitamin‑minerals” contain hidden quercetin.
• Consult a pharmacist or dietitian before adding any new supplement.
• Monitor for lingering symptoms – periodic check‑ups for fatigue or neuropathy.
• Stress management – chronic inflammation can be mitigated with exercise, adequate sleep, and mindfulness.

Prevention

Because quercetin is widely marketed as a “natural” health aid, prevention relies on education and safe supplement practices.

1. Follow Recommended Daily Allowances – the European Food Safety Authority (EFSA) suggests no more than 500 mg/day from supplemental sources.
2. Avoid “megadose” regimes – regimens >1 g/day have no solid evidence of benefit and increase toxicity risk.
3. Screen for interactions – ask clinicians about any prescription drugs, especially anticoagulants (e.g., warfarin) and CYP3A4 inhibitors.
4. Prefer food‑based intake – one medium onion (~20 mg quercetin) or a cup of blueberries (~15 mg) provides antioxidant benefits without overexposure.
5. Use third‑party verified products – look for USP, NSF, or ConsumerLab certification.

Complications

If not recognized and treated, QOS can lead to serious sequelae:

• Acute kidney injury – may progress to chronic kidney disease.
• Severe hepatotoxicity – rare cases of fulminant hepatitis requiring transplantation.
• Permanent peripheral neuropathy – especially with prolonged high‑dose use.
• Electrolyte‑related cardiac arrhythmias – hypokalemia can precipitate ventricular tachycardia.
• Recurrent kidney stones – leading to obstruction or infection.

When to Seek Emergency Care

---

Sources: Mayo Clinic. “Quercetin: Uses, Side Effects, Interactions.” 2023; CDC. “Adverse Event Reporting System (FAERS) – Dietary Supplements.” 2022; NIH Office of Dietary Supplements. “Quercetin Fact Sheet for Health Professionals.” 2021; European Food Safety Authority (EFSA). “Scientific Opinion on the safety of quercetin.” 2020; Cleveland Clinic. “Herbal Supplement Toxicity.” 2022; Journal of Clinical Gastroenterology. “N‑acetylcysteine in Flavonoid‑Induced Hepatotoxicity.” 2021.

```